140 related articles for article (PubMed ID: 33848569)
21. Comparison of opioid rotation on pain, symptoms, and daily opioid dose in a supportive care clinic.
Legakis LP; Woo W; Cassel JB; Del Fabbro E
Ann Palliat Med; 2021 Jun; 10(6):6336-6343. PubMed ID: 34118844
[TBL] [Abstract][Full Text] [Related]
22. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
Laugsand EA; Fladvad T; Skorpen F; Maltoni M; Kaasa S; Fayers P; Klepstad P
Eur J Cancer; 2011 Jul; 47(11):1682-91. PubMed ID: 21570824
[TBL] [Abstract][Full Text] [Related]
23. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
[TBL] [Abstract][Full Text] [Related]
24. Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain.
Yennurajalingam S; Arthur J; Reddy S; Edwards T; Lu Z; Rozman de Moraes A; Wilson SM; Erdogan E; Joy MP; Ethridge SD; Kuriakose L; Malik JS; Najera JM; Rashid S; Qian Y; Kubiak MJ; Nguyen K; PharmD ; Wu J; Hui D; Bruera E
JAMA Oncol; 2021 Mar; 7(3):404-411. PubMed ID: 33410866
[TBL] [Abstract][Full Text] [Related]
25. Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
Olesen AE; Grønlund D; Gram M; Skorpen F; Drewes AM; Klepstad P
BMC Res Notes; 2018 Jan; 11(1):78. PubMed ID: 29374492
[TBL] [Abstract][Full Text] [Related]
26. Acute pain Factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement.
Thomazeau J; Rouquette A; Martinez V; Rabuel C; Prince N; Laplanche JL; Nizard R; Bergmann JF; Perrot S; Lloret-Linares C
Eur J Pain; 2016 May; 20(5):822-32. PubMed ID: 26517014
[TBL] [Abstract][Full Text] [Related]
27. OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
Hajj A; Halepian L; Osta NE; Chahine G; Kattan J; Rabbaa Khabbaz L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346387
[TBL] [Abstract][Full Text] [Related]
28. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
29. Multiple Loci modulate opioid therapy response for cancer pain.
Galvan A; Skorpen F; Klepstad P; Knudsen AK; Fladvad T; Falvella FS; Pigni A; Brunelli C; Caraceni A; Kaasa S; Dragani TA
Clin Cancer Res; 2011 Jul; 17(13):4581-7. PubMed ID: 21622719
[TBL] [Abstract][Full Text] [Related]
30. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma.
Khalil H; Sereika SM; Dai F; Alexander S; Conley Y; Gruen G; Meng L; Siska P; Tarkin I; Henker R
Biol Res Nurs; 2017 Mar; 19(2):170-179. PubMed ID: 27903758
[TBL] [Abstract][Full Text] [Related]
31. The pattern of change in opioid and adjuvant prescriptions for cancer pain before and after referral to a comprehensive program in the Palliative Care Center in Kuwait.
Al-Ansari AM; Abd-El-Gawad WM; AboSerea SM; ElShereafy EES; Ali FAS; ElSayed MAE
BMC Palliat Care; 2021 Feb; 20(1):25. PubMed ID: 33536013
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
33. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.
Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL
J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745
[TBL] [Abstract][Full Text] [Related]
34. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
[TBL] [Abstract][Full Text] [Related]
35. The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation.
Henker RA; Lewis A; Dai F; Lariviere WR; Meng L; Gruen GS; Sereika SM; Pape H; Tarkin IS; Gowda I; Conley YP
Biol Res Nurs; 2013 Jul; 15(3):309-17. PubMed ID: 22718527
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
37. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with Improvement in Uncontrolled Cancer Pain without Increasing the Opioid Daily Dose among Patients Seen by an Inpatient Palliative Care Team.
Qian Y; Haider A; Lu Z; Naqvi S; Zhuang A; Nguyen K; Reddy A; Arthur J; Tanco K; Williams J; Wu J; Liu D; Naberhuis J; Bruera E
J Palliat Med; 2020 Apr; 23(4):483-488. PubMed ID: 31687882
[No Abstract] [Full Text] [Related]
39. Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study.
Yokoshima Y; Sumitani M; Nishizawa D; Nagashima M; Ikeda K; Kato R; Hozumi J; Abe H; Azuma K; Tsuchida R; Yamada Y;
Neuropsychopharmacol Rep; 2018 Dec; 38(4):175-181. PubMed ID: 30277654
[TBL] [Abstract][Full Text] [Related]
40. The development of a nomogram to determine the frequency of elevated risk for non-medical opioid use in cancer patients.
Yennurajalingam S; Edwards T; Arthur J; Lu Z; Erdogan E; Malik JS; Naqvi SMA; Wu J; Liu DD; Williams JL; Hui D; Reddy SK; Bruera E
Palliat Support Care; 2021 Feb; 19(1):3-10. PubMed ID: 32729447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
